Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/26/2020 9:08:10 PM - Followers: 46 - Board type: Free - Posts Today: 0
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Demonstrated Clinically Meaningful Tumor Response Rates in... 05/28/2020 06:37:00 PM
MRK News: Merck’s KEYTRUDA® (pembrolizumab) Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer 05/28/2020 05:00:00 PM
MRK News: Merck Announces Third-Quarter 2020 Dividend 05/26/2020 12:37:00 PM
MRK News: Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801 05/26/2020 06:51:00 AM
MRK News: IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2 05/26/2020 06:49:00 AM
News News Alert: KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Demonstrated Clinically Meaningful Tumor Response Rates in... 05/28/2020 06:37:00 PM
PostSubject
#508  Sticky Note Spinoff of women’s health/off-patent brands/biosimilars into new (as DewDiligence 02/05/20 08:20:57 AM
#532   Merck is relatively cheap with a p/e multiple LionsTact 05/26/20 09:08:09 PM
#531   MRK goes all-in on COVID-19 with three deals… DewDiligence 05/26/20 09:43:28 AM
#530   FDA approves Lynparza in second-line CRPC with HRR mutations: DewDiligence 05/20/20 01:29:23 PM
#529   MRK’s women’s-health/branded-generics/biosimilars spin-off will be called…Organo DewDiligence 04/28/20 10:05:16 PM
#528   FDA approves q6w dosing for Keytruda monotherapy indications: DewDiligence 04/28/20 05:14:15 PM
#527   MRK cuts 2020 guidance due to heavy reliance DewDiligence 04/28/20 03:15:47 PM
#526   MRK/AZN—Lynparza shows statsig-superior OS to hormonal agents (Xtandi, DewDiligence 04/24/20 12:51:00 PM
#525   Your prescience is acknowledged. Nice. Trueheart 04/23/20 12:10:19 PM
#524   I bought MRK in 2013 (#msg-88261837). DewDiligence 04/22/20 10:23:52 AM
#523   I'm not. I got in at $80. Trueheart 04/22/20 02:11:24 AM
#522   Who is Green? DewDiligence 04/21/20 05:32:57 PM
#521   In 2017, Green lobbied the Senate on behalf tw0122 04/21/20 08:46:06 AM
#520   FDA approves MRK’ Herceptin biosimilar, called Ontruzant: DewDiligence 04/15/20 09:15:49 AM
#519   Bought 50 shares at $80. Trueheart 04/08/20 02:25:39 PM
#518   MRK—Keytruda-monotherapy BLA in TMB-high tumors has 6/16/20 PDUFA DewDiligence 04/07/20 10:23:58 AM
#517   MRK’s KEYNOTE-177 succeeds in 1L-MSI-H/dMMR CRC, which should DewDiligence 04/02/20 11:07:42 AM
#516   MRK highlights HIV pipeline at CROI: DewDiligence 03/02/20 08:09:27 AM
#515   Early Bird gets a bird worm. Must-Read Now: Skiluc 02/22/20 05:01:51 PM
#514   I thought I read they got some type ezyE 02/20/20 05:24:12 AM
#513   A Complete Response Letter from the FDA is DewDiligence 02/19/20 03:40:03 PM
#512   Why didn't this go higher with the news ezyE 02/19/20 03:00:19 PM
#511   Keytruda/chemo showed statsig-better PFS than chemo alone in DewDiligence 02/12/20 11:13:57 AM
#510   MRK 4Q19 CC transcript: DewDiligence 02/06/20 09:52:26 AM
#509   4Q19 results and 2020 guidance… DewDiligence 02/05/20 08:45:57 AM
#508   Spinoff of women’s health/off-patent brands/biosimilars into new (as DewDiligence 02/05/20 08:20:57 AM
#507   Let’s be up on a real red day. grich1 01/27/20 02:58:30 PM
#506   FDA approves Keytruda monotherapy for second-line NMIBC, regardless DewDiligence 01/08/20 02:51:17 PM
#505   FDA approves MRK's ebola vaccine, Erbivo: DewDiligence 12/20/19 10:36:50 AM
#503   What is your outlook on this over the Philmasta 12/17/19 11:23:57 PM
#502   MRK acquires ARQL for $2.7B: DewDiligence 12/09/19 11:48:16 AM
#501   Keytruda PDUFA date in NMIBC is Jan 2020 DewDiligence 12/02/19 03:22:29 PM
#500   If they beat cancer what will mrk pps AllGold818 11/26/19 09:21:24 PM
#499   China approves MRK’s Keytruda in first-line NSCLC: DewDiligence 11/26/19 10:22:04 AM
#498   MRK raises dividend 11% to annualized $2.44 (from $2.20): DewDiligence 11/19/19 02:54:17 PM
#497   https://www.nature.com/articles/s41467-019-12406-z north40000 11/14/19 02:12:01 AM
#496   https://www.newswise.com/articles/fertilization-discovery-reveals-new-role-for-the-egg-could-lead-to north40000 11/14/19 02:05:48 AM
#495   Pfizer and Merck’s third-quarter numbers bolster hopes for jonny_red 10/29/19 11:37:42 AM
#494   MRK raised 2019 non-GAAP-EPS guidance to $5.12-5.17 (from DewDiligence 10/29/19 10:14:04 AM
#493   MRK 3Q19 items… DewDiligence 10/29/19 07:41:46 AM
#492   Today’s -4% move may have been reasonable: #msg-151855642. DewDiligence 10/22/19 07:32:11 PM
#491   https://oncologie.international/oncologie-announces-first-patient-enrolled-in-global-phase-2-study-o north40000 10/10/19 02:10:13 AM
#490   Dew, The fact that higher blood EPA levels couldbebetter 10/04/19 10:03:01 PM
#489   "A combination with Zocor[a statin] might make sense, north40000 10/04/19 08:58:05 PM
#488   Would clinical trials that involve Amarin’s Vascepa and DewDiligence 10/04/19 08:13:54 PM
#487   Would clinical trials that involve Amarin’s Vascepa and north40000 10/04/19 08:10:44 PM
#486   Well if not there ... at least on Whalatane 10/04/19 07:05:13 PM
#485   North. You and Dew are. “ trending Whalatane 10/04/19 07:03:45 PM
#484   AMRN— I sure would love to see Vascepa DewDiligence 10/04/19 05:53:26 PM
#483   MRK: Views on a future MRK acquisition, AMRN north40000 10/04/19 03:57:09 PM
#482   Keytruda active in neoadjuvant/adjuvant TNBC— (KEYNOTE-522 interim results): DewDiligence 09/29/19 11:33:04 AM
PostSubject